Skip to content

Mathis Pharma

Active Risk: not assessed Private limited companyfounded 2006active for 20 yearsAstridlaan 374a, 8310 BrugesKBO/BCE: BE 0882.624.180

Board

1 director, last change in 2024
Director (not named in the articles)
appointed by deed of 27-03-2024 term without a fixed end
earlier manager (not named in the articles), until 27-03-2024
listed in the 2025 annual accounts, filed on 30-08-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“*De bestuurder kiest voor alle materies die aan de uitoefening van zijn mandaat raken, woonplaats op de zetel van de vennootschap. *Het…”
deed of 27-03-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
DESCHILDER Isabelle Kate Blanche
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • DESCHILDER Isabelle Kate Blanche
    • Director (not named in the articles), from 01-07-2006 to date
    • Manager (not named in the articles), until 27-03-2024

Control

Capital

Contribution
€18,600
Source
2025 annual accounts

Articles of association

deed of 27-03-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Uitdrukkelijk akkoord bestuurde vennootschap, niet bezoldigd tenzij algemene vergadering bij benoeming anders beslist”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June at 20:00

Next steps